Biohit Oyj - Managers' Transactions Biohit Oyj -
Post# of 301275
(Total Views: 76)
Posted On: 03/03/2017 5:00:15 AM
Biohit Oyj - Managers' Transactions
Biohit Oyj - Managers' Transactions, March 3, 2017 at 11:00 am local time (EET)
| Person subject to the notification requirement | ||
| Name: | Korpela, Semi | |
| Position: | Chief Executive Officer | |
| Initial Notification | ||
| Reference number: | 74370089ATTSNBXJVT29_20170302113238_1 | |
| Issuer | ||
| Name: | Biohit Oyj | |
| LEI: | 74370089ATTSNBXJVT29 | |
| Transaction details | ||
| Transaction date: | 2017-03-01 | |
| Venue: | NASDAQ HELSINKI LTD (XHEL) | |
| Nature of the transaction: | Acquisition | |
| Instrument: | Share | |
| ISIN: | FI0009005482 | |
| Volume: | 1240 | |
| Unit price: | 5,29000 Euro | |
| Aggregated transactions | ||
| Volume: | 1240 | |
| Volume weighted average price: | 5.29000 Euro | |
Additional information:
CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com
(0)
(0)Scroll down for more posts ▼